Advances in the Management of R/R cHL
Advances in the Management of R/R cHL
John Kuruvilla
KEYNOTE-204 in R/R cHL: How Does This Trial Influence Our Practice?
- 88 views
- March 11, 2022
ASH 2021 Conference Coverage on VuMedi
ASH 2021 Five-Year Follow-Up of Keynote-087: Pembrolizumab Monotherapy in R/R cHL
FEATURING
Alex Herrera
- 271 views
- March 24, 2022
- 1
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Integrating Novel Agents Into the Treatment of Classic HL
FEATURING
Ann LaCasce
- 65 views
- October 1, 2021
UNC Lineberger Comprehensive Cancer Center
Latest Advances in the Management of R/R cHL: The Era of Novel Therapies
FEATURING
Natalie Grover
- 153 views
- March 23, 2022
- 1
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2022
Advanced Stage Hodgkin Lymphoma in 2022: Common Management Issues
FEATURING
Craig Moskowitz
- 313 views
- April 6, 2022
- 1
University of Colorado Division of Hematology
UC Denver ASH Review: Updates on Lymphomas
FEATURING
Steven Bair
- 73 views
- March 16, 2022
Penn Medicine Abramson Cancer Center
Therapeutic Advances in Hodgkin Lymphoma
FEATURING
Jakub Svoboda
- 115 views
- May 6, 2022
Penn Medicine Abramson Cancer Center
Equitable Access to Hematologic Malignancies Research for Everyone
FEATURING
Carmen Guerra
- 61 views
- May 2, 2022
